KRAS and neoplasm: The relative frequencies of the different possible KRAS substitutions within each tumor type were highly similar between the local cohort, and the TCGA, and showed no significant differences between the two datasets (P > 0.05 for all comparisons according to a χ2 test, Fig. 1, Table S2).